Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation

Status Completed

Clinical Trial Summary

The purpose of this study is to determinate if mediyoga has effects in quality of life, heart rate variability, blood pressure , heart rate in patients with paroxysmal atrial fibrillation (PAF).

Clinical Trial Description

This is randomized prospective pilot study. Eighty patients from Danderyd hospital, Stockholm, Sweden were randomized to either mediyoga group or control group. The mediyoga group were completing yoga for one hour, once a week for 12 weeks together with usual treatment. The controlgroup had only usual treatment.The usual treatment consists of pharmaceutical, cardio version and ablation. Quality of life ( SF-36, EQ-5d), blood pressure, heart rate and 24-hours ekokardiografi were measured at baseline and after twelve weeks.A follow up after six months was accomplished with SF-36 and EQ-5d, bloodpressure and heart rate. ;

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01789372
Study type	Observational
Source	Danderyd Hospital
Contact
Status	Completed
Phase	N/A
Start date	December 2009
Completion date	June 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05970120` - A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter	N/A
Recruiting	`NCT06014996` - Comparison of PFA vs. RFA in Patients With Symptomatic Paroxysmal Atrial Fibrillation.	N/A
Completed	`NCT03624881` - Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)	Phase 4
Recruiting	`NCT05416086` - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study	N/A
Recruiting	`NCT05905835` - Treatment of PAF With the Synaptic System	N/A
Active, not recruiting	`NCT05618340` - PFA for Paroxysmal Atrial Fibrillation	N/A
Active, not recruiting	`NCT05534581` - SINGLE SHOT CHAMPION	Phase 4
Not yet recruiting	`NCT05024630` - Renal Denervation and pUlmonary Vein isolAtion With cryoabLation on Patients With Atrial Fibrillation and hypErtension	N/A
Completed	`NCT02610803` - Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke	N/A
Completed	`NCT01913522` - Cryoballoon vs. Irrigated Radiofrequency Catheter Ablation: Double Short vs. Standard Exposure Duration	N/A
Terminated	`NCT01925885` - Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)	N/A
Withdrawn	`NCT01917981` - Testing the Accuracy of a Personal Heart Rhythm Monitor to Detect Prolonged Paroxysmal Atrial Fibrillation	Phase 3
Completed	`NCT01842529` - Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac Surgery	Phase 2
Completed	`NCT01693107` - Atrial Fibrillation Force Contact Ablation Study
Completed	`NCT00971204` - Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation	Phase 2
Completed	`NCT05043883` - Automated Assessment of PVI Using a Novel EP Recording System	N/A
Recruiting	`NCT05172765` - Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)	N/A
Recruiting	`NCT04529785` - Added Value of Vein of Marshal Ethanol Infusion Compared to Superior Vena Cava Isolation Alone in Patients Undergoing Repeat Ablation for Recurrent Paroxysmal Atrial Fibrillation Despite Durable PV Isolation	N/A
Completed	`NCT04022954` - HD Mapping of Atrial Fibrillation in Asia Pacific
Completed	`NCT00964392` - NAVISTAR® THERMOCOOL® Catheter Post Approval Registry	Phase 4